Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb;10(2):1058-1066.
doi: 10.21037/jtd.2018.01.95.

Screen-detected multiple primary lung cancers in the ITALUNG trial

Affiliations

Screen-detected multiple primary lung cancers in the ITALUNG trial

Mario Mascalchi et al. J Thorac Dis. 2018 Feb.

Abstract

Occurrence of multiple primary lung cancers (MPLC) in individuals undergoing low-dose computed tomography (LDCT) screening has not been thoroughly addressed. We investigated MPLC in subjects recruited in the ITALUNG randomized clinical trial. Cases of cytologically/histologically proven MPLC detected at screening LDCT or follow-up CT were selected and pathologically re-evaluated according to the WHO 2015 classification. Overall 16 MPLC were diagnosed at screening LDCT (n=14, all present at baseline) or follow-up CT (n=2) in six subjects (4 in one subject, 3 in two and 2 in three subjects), representing 0.43% of the 1,406 screenees and 15.8% of the 38 subjects with at least one screen-detected primary lung cancer. MPLC included 9 adenocarcinomas in three subjects and a combination of 7 different tumour histotypes in three subjects. MPLC, mostly adenocarcinomas, are not uncommon in smokers and ex-smokers with at least one LDCT screen detected primary lung cancer.

Keywords: Multiple primary lung cancer; adenocarcinoma; low-dose CT screening; lung cancer.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Case I (Table 1). Four primary adenocarcinomas in a 70-year-old smoker, which were all detected at baseline LDCT screening round. They appeared as a spiculated lung nodule in the right upper lobe (RUL) (A), a ground glass opacity in the same lobe (B), a small solid nodule in the right lower lobe (RLL) (arrow in C) and a ground glass opacity with a small solid component in the left upper lobe (LUL) (D). Haematoxylin and eosin histologic staining (original magnification ×200) demonstrate an invasive adenocarcinoma, acinar predominant (E) in the RUL lesion corresponding to (A), an invasive adenocarcinoma, lepidic predominant (F) in the RUL lesion corresponding to (B) and an invasive adenocarcinoma, acinar predominant (G) in the RLL lesion corresponding to (C). Papanicolaou stain (original magnification ×40) of fine needle aspiration biopsy shows papillary pattern of uniform malignant cells with irregular nuclei consistent with adenocarcinoma (H) in the LUL lesion corresponding to (D).
Figure 2
Figure 2
Case II (Table 1). Adenocarcinoma and small cell lung cancer in a 61-year-old smoker both detected at baseline LDCT screening round. They appeared as a rounded lung nodule in the RUL and a subpleural small solid nodule (arrow) in the LUL (A). Haematoxylin and eosin histologic staining demonstrate invasive adenocarcinoma, acinar predominant (original magnification ×200) (B) in the RUL lesion and small cell lung carcinoma (original magnification ×100) (C) in the LUL lesion.

References

    1. Slaughter DP, Southwich HW, Smejkal W. “Field cancerization” in oral stratified squamous epithelium: clinical implications of multi-centric origin. Cancer 1953;6:963-8. 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q - DOI - PubMed
    1. Kadara H, Wistuba II. Field cancerization in non-small cell lung cancer: implications in disease pathogenesis. Proc Am Thorac Soc 2012;9:38-42. 10.1513/pats.201201-004MS - DOI - PMC - PubMed
    1. Voltolini L, Rapicetta C, Luzzi L., et al. Surgical treatment of synchronous multiple lung cancer located in a different lobe or lung: high survival in node negative subgroup. Eur J Cardiothorac Surg 2010;37:1198-204. 10.1016/j.ejcts.2009.11.025 - DOI - PubMed
    1. Paci E, Puliti D, Lopes Pegna A, et al. Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial. Thorax 2017;72:825-31. 10.1136/thoraxjnl-2016-209825 - DOI - PubMed
    1. Picozzi G, Paci E, Lopes-Pegna A, et al. Screening of lung cancer with low-dose spiral CT: results of a three-year pilot study and design of the randomized controlled trial “Italung-CT”. Radiol Med 2005;109:17-26. - PubMed

LinkOut - more resources